** Shares of drugmaker Ionis Pharmaceuticals IONS.O rise 6% to $31.65
** IONS ups 2025 sales forecast to $725 mln to $750 mln, up from prior forecast of at least $600 mln; analysts were expecting 2025 sales to be $659.7 mln - LSEG
** IONS posts Q1 sales of $132 mln vs analysts' est of $125.3 mln - LSEG
** IONS reports Q1 loss of 93 cents, compared with a loss of 98 cents a year ago
** As of last close, stock down 14.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。